SummaryThe structural effects of three missense mutations clinically linked to hypertrophic cardiomyopathy (HCM) and located in the central domains of cardiac myosin-binding protein C (cMyBP-C) have been determined using small-angle scattering, infrared spectroscopy, and nuclear magnetic resonance spectroscopy. Bioinformatics and modeling were used to initially predict the expected structural impacts and assess the broader implications for function based on sequence conservation patterns. The experimental results generally affirm the predictions that two of the mutations (D745G, P873H) disrupt domain folding, while the third (R820Q) is likely to be entirely solvent exposed and thus more likely to have its impact through its interactions wit...
Hypertrophic cardiomyopathy (HCM), a disease characterized by cardiac muscle hypertrophy and hyperco...
AIMS: A 25-base pair (bp) deletion in the cardiac myosin binding protein-C (cMyBP-C) gene (MYBPC3), ...
Most familial dilated and hypertrophic cardiomyopathies are caused by mutations in sarcomeric protei...
Cardiac myosin binding protein-C (cMyBPC) is a modular protein consisting of 11 domains whose precis...
Sarcomeric proteins are essential for the proper structural assembly and functioning of the sarcomer...
Human cardiac myosin binding protein C (cMyBP-C), a thick filament protein found within the sarcomer...
Cardiac myosin binding protein-C (cMyBP-C) is a multi-domain (C0–C10) protein that regulates heart m...
AbstractThe impact of three mutations of domain C5 from myosin binding protein C, correlated to Fami...
C-protein is a major component of skeletal and cardiac muscle thick filaments. Mutations in the gene...
Cardiac β-myosin variants cause hypertrophic (HCM) or dilated (DCM) cardiomyopathy by disrupting sar...
The most common inherited cardiac disorder, hypertrophic cardiomyopathy (HCM), is characterized by t...
Aims: We tested the hypothesis that mutations in the human ventricular essential myosin light chain ...
Hypertrophic cardiomyopathy(HCM)results from mutations in genes encoding sarcomeric proteins, most o...
BACKGROUND: Mutations in MYBPC3 are the most common cause of hypertrophic cardiomyopathy (HCM). Thes...
Thermal folding Molecular Dynamics simulations of the domain C5 from Myosin Binding Protein C were p...
Hypertrophic cardiomyopathy (HCM), a disease characterized by cardiac muscle hypertrophy and hyperco...
AIMS: A 25-base pair (bp) deletion in the cardiac myosin binding protein-C (cMyBP-C) gene (MYBPC3), ...
Most familial dilated and hypertrophic cardiomyopathies are caused by mutations in sarcomeric protei...
Cardiac myosin binding protein-C (cMyBPC) is a modular protein consisting of 11 domains whose precis...
Sarcomeric proteins are essential for the proper structural assembly and functioning of the sarcomer...
Human cardiac myosin binding protein C (cMyBP-C), a thick filament protein found within the sarcomer...
Cardiac myosin binding protein-C (cMyBP-C) is a multi-domain (C0–C10) protein that regulates heart m...
AbstractThe impact of three mutations of domain C5 from myosin binding protein C, correlated to Fami...
C-protein is a major component of skeletal and cardiac muscle thick filaments. Mutations in the gene...
Cardiac β-myosin variants cause hypertrophic (HCM) or dilated (DCM) cardiomyopathy by disrupting sar...
The most common inherited cardiac disorder, hypertrophic cardiomyopathy (HCM), is characterized by t...
Aims: We tested the hypothesis that mutations in the human ventricular essential myosin light chain ...
Hypertrophic cardiomyopathy(HCM)results from mutations in genes encoding sarcomeric proteins, most o...
BACKGROUND: Mutations in MYBPC3 are the most common cause of hypertrophic cardiomyopathy (HCM). Thes...
Thermal folding Molecular Dynamics simulations of the domain C5 from Myosin Binding Protein C were p...
Hypertrophic cardiomyopathy (HCM), a disease characterized by cardiac muscle hypertrophy and hyperco...
AIMS: A 25-base pair (bp) deletion in the cardiac myosin binding protein-C (cMyBP-C) gene (MYBPC3), ...
Most familial dilated and hypertrophic cardiomyopathies are caused by mutations in sarcomeric protei...